- 光算蜘蛛池
上交所公開信息顯示
时间：2010-12-5 17:23:32 作者：光算爬蟲池 来源：光算穀歌外鏈 查看： 评论：0内容摘要：（文章來源：證券時報網）成交額8780.01萬元。上交所公開信息顯示，龍虎榜光算蜘蛛池數據顯示，當日該股因日漲幅偏離值達8.79%上榜，營業部席位合計淨買入926.27萬元。營業部席位合計淨買入926（文章來源：證券時報網）成交額8780.01萬元。
上交所公開信息顯示，龍虎榜
- 最近更新
- 2025-06-17 20:57:11上海歌劇院原創民族歌劇走進徐匯校園，唱響“開學第一課”
- 2025-06-17 20:57:11“剩菜盲盒”是撿漏福利？臨期食品到底該不該買？
- 2025-06-17 20:57:11有色/貴金屬 | 短期鋁價偏弱震蕩 短線建議反彈偏空對待
- 2025-06-17 20:57:11河南省最新高速路況：因降雪、凍雨和結冰 這些路段禁止車輛上站
- 2025-06-17 20:57:11蘇泊爾：預計2023年歸母淨利潤21.7億元-21.9億元 同比增4.95%-5.92%
- 2025-06-17 20:57:11華大基因披露2023年度業績預告 多元舉措築牢高質量發展根基
- 2025-06-17 20:57:11海融科技：2月19日召開董事會會議
- 2025-06-17 20:57:11科創板晚報 | 上海發布2024年14項科技產業類計劃建成重大工程 源傑科技、奧比中光等擬回購
- 热门排行
- 2025-06-17 20:57:11貝斯特：2024年第一季度淨利潤約6924萬元 同比增加29.44%
- 2025-06-17 20:57:11有信心有幹勁 滬市公司以高質量發展夯實經濟重要微觀基礎
- 2025-06-17 20:57:11合規內控存四類問題 國信證券被深圳證監局出具警示函
- 2025-06-17 20:57:11多倫科技：擬以3000萬元-6000萬元回購股份
- 2025-06-17 20:57:11江西永新優化全產業鏈布局—— 傳統產業逐綠而行
- 2025-06-17 20:57:11傅園慧包車遭半路加錢： 掃除“路障”是一個係統的工程
- 2025-06-17 20:57:11注意！成都燃氣將於5月10日召開股東大會
- 2025-06-17 20:57:11歐盟《數字市場法案》能否真正撼動科技巨頭的市場地位？
- 友情链接
- https://synapse.patsnap.com/drug/12d5810ce8f54bf3a105cb4640ccf008
- https://synapse.patsnap.com/article/what-are-the-therapeutic-applications-for-tslp-inhibitors
- https://synapse.patsnap.com/drug/8f47098cd4a47841cd47001f23c5510b
- https://synapse.patsnap.com/drug/9aa898cca76c4355a70d16078b236a03
- https://synapse.patsnap.com/drug/f6cd5821398241d7a124d3d53aa9bbb7
- https://synapse.patsnap.com/drug/9279bbabbdd840d98319d22204d090c1
- https://synapse.patsnap.com/drug/9e5e2c8a2d7b4e8491a6b5d6aed9a6c6
- https://synapse.patsnap.com/drug/fced4911cfba4cacb690b7ab5ced8f70
- https://synapse.patsnap.com/article/tisotumab-vedotin-phase-2-data-shows-promise-in-recurrent-or-metastatic-hnscc
- https://synapse.patsnap.com/article/what-is-the-mechanism-of-diflucortolone-valerate
- https://synapse.patsnap.com/drug/39d08d4a2388424eb0de7196ddd9ee56
- https://synapse.patsnap.com/article/what-are-the-future-directions-for-research-and-development-of-tysabri
- https://synapse.patsnap.com/drug/a6beaa4e60334f90b53eb25d9bc64fb0
- https://synapse.patsnap.com/article/whats-the-latest-update-on-the-ongoing-clinical-trials-related-to-primary-biliary-cholangitis
- https://synapse.patsnap.com/blog/eu-approves-first-sanofi-regeneron-drug-dulprizumab-for-copd
- https://synapse.patsnap.com/article/what-is-the-mechanism-of-dipyrocetyl
- https://synapse.patsnap.com/drug/6e907ba3cef24fa18f5ccc3f8fe2fd0a
- https://synapse.patsnap.com/article/low-dose-rapamycin-regulated-sc-daric33-advancing-cd33-targeted-car-t-cell-therapy-for-acute-myeloid-leukemia
- https://synapse.patsnap.com/article/what-are-interferon-agonists-and-how-do-they-work
- https://synapse.patsnap.com/article/merck-pursues-oral-peptide-delivery-in-493m-cyprumed-deal
- https://synapse.patsnap.com/article/what-is-the-mechanism-of-mazindol
- https://synapse.patsnap.com/article/what-is-the-mechanism-of-nsc-631570
- https://synapse.patsnap.com/drug/696e285b61a54a2190caf4c67ca594bc
- https://synapse.patsnap.com/article/acurx-pharmaceuticals-announces-q2-2024-results-and-business-update
- https://synapse.patsnap.com/drug/a68f540f108d40f09a7701770c22fae4
- https://synapse.patsnap.com/drug/a9f5919c2a664f0db3a7585b63e131f4
- https://synapse.patsnap.com/drug/88f2ee4329504db8a9056c3d33af50dd
- https://synapse.patsnap.com/drug/d74259fef2a0e2be7a22468bb9203a41
- https://synapse.patsnap.com/article/what-are-the-side-effects-of-xipamide
- https://synapse.patsnap.com/article/sensei-biotherapeutics-shows-promising-phase-1-data-for-sns-101
copyright © 2016 powered by seo教程合集app推廣 sitemap